0001829255-25-000001.txt : 20250716 0001829255-25-000001.hdr.sgml : 20250716 20250716170408 ACCESSION NUMBER: 0001829255-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250716 DATE AS OF CHANGE: 20250716 EFFECTIVENESS DATE: 20250716 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Halia Therapeutics, Inc. CENTRAL INDEX KEY: 0001829255 ORGANIZATION NAME: EIN: 822679083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-552038 FILM NUMBER: 251128020 BUSINESS ADDRESS: STREET 1: 222 S. MAIN STREET, SUITE 500 CITY: SALT LAKE CITY STATE: UT ZIP: 84101 BUSINESS PHONE: 801-753-5707 MAIL ADDRESS: STREET 1: 222 S. MAIN STREET, SUITE 500 CITY: SALT LAKE CITY STATE: UT ZIP: 84101 D 1 primary_doc.xml X0708 D LIVE 0001829255 Halia Therapeutics, Inc. 3900 N. Traverse Mountain Blvd Suite 100 Lehi UT UTAH 84043 385-355-4315 DELAWARE None None Corporation true Jeffrey Burton 3900 N. Traverse Mountain Blvd Suite 100 Lehi UT UTAH 84043 Executive Officer David Bearss 3900 N. Traverse Mountain Blvd Suite 100 Lehi UT UTAH 84043 Executive Officer Director Jared Bearss 3900 N. Traverse Mountain Blvd Suite 100 Lehi UT UTAH 84043 Director John S.K. Kauwe 3900 N. Traverse Mountain Blvd Suite 100 Lehi UT UTAH 84043 Director Todd Pedersen 3900 N. Traverse Mountain Blvd Suite 100 Lehi UT UTAH 84043 Director Gary B. Sabin 3900 N. Traverse Mountain Blvd Suite 100 Lehi UT UTAH 84043 Director Jim Savas 3900 N. Traverse Mountain Blvd Suite 100 Lehi UT UTAH 84043 Director Biotechnology Decline to Disclose 06b false 2025-07-01 false true false 0 19999996 336833 19663163 false 5 0 0 0 false Halia Therapeutics, Inc. Jeffrey Burton Jeffrey Burton Chief Financial Officer 2025-07-16